Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 1.2% | n/a |
ROCE | 1.5% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.1 | n/a |
Pr/Book | 1.0 |
Latest | F'cast | |
---|---|---|
Revenue | 8.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 16.47 | (13.15) | (28.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 19.75 | (5.14) | (7.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 24.48 | (2.83) | (3.83)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 26.32 | (1.89) | (2.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 28.65 | (0.56) | (1.20)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Final results for the year ended 31 December 2024 | 25-Jun-2025 | 07:00 | RNS |
CE & UKCA certification for OrthoPure® XT | 09-Jun-2025 | 07:00 | RNS |
Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc | 24-Apr-2025 | 09:38 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 29.50p |
Change Today | -1.50p |
% Change | -4.84 % |
52 Week High | 74.00 |
52 Week Low | 29.00 |
Volume | 56,004 |
Shares Issued | 71.40m |
Market Cap | £21.06m |
Beta | 0.00 |
RiskGrade | 22 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:07 | 1,886 @ 29.05p |
15:52 | 439 @ 29.00p |
15:52 | 3 @ 30.00p |
15:52 | 6,146 @ 29.05p |
15:26 | 3,313 @ 30.00p |
You are here: research